The 53rd Annual Meeting of the Scandinavian Society for the Study of Diabetes (SSSD)

Oral Presentations – Wednesday afternoon

Autoantigen (GAD-alum) given into lymph-nodes together with oral Vitamin D to preserve beta cell function in Type 1 diabetes. The DIAGNODE-1 pilot trial.
Ludvigsson Johnny, Tavira Beatriz, Barcenilla Hugo, Wahlberg Jeanette, Casas Rosaura, Sweden

Who are the ones discontinuing insulin pump treatment?
Päivi Hannula, Aki Järvelä, Saara Metso and Jorma T. Lahtela, Finland

Higher intraindividual HDL-cholesterol and triglyceride variability are associated with the development and progression of diabetic nephropathy in individuals with type 1 diabetes
Fanny Jansson, Carol Forsblom, Lena Thorn, Valma Harjutsalo, Nina Elonen, Emma Dahlström, Niina Sandholm, and Per-Henrik Groop, on behalf of the FinnDiane Study Group, Finland

Semiautomatic analysis of the retinal vasculature of a young T1D cohort with SIVA
Carolin Schanner, Nina Hautala, Aura Falck, Finland

Genetic determinants of glycated hemoglobin in type 1 diabetes
Anna M Syreeni, Niina K A Sandholm, Iiro Toppila, Jingjing Cao, Carol Forsblom, Valma Harjutsalo, Erkka Valo, Maija Parkkonen, Andrew D. Paterson, Per-Henrik Groop on behalf of the FinnDiane Study Group, Finland, Canada, Australia

Shard genetic influence of smoking, smokeless tobacco use adn t2: a twin study
Sofia Carlsson, Ralf Kula-Hajkola, Cecilia Magnusson, Ylva Trolle-Lagerros, Tomas Andersson, Sweden

A common intergenic variant on chromosome 11 associates with a favorable metabolic phenotype in Greenlanders
Mette K. Andersen, Camilla H. Sandholt, Ida Moltke, Niels Grarup, Peter Bjerregaard, Christina V.L. Larsen, Inger K. Dahl-Petersen, Emil Jørsboe, Oluf Pedersen, Marit E. Jørgensen, Anders Albrechtsen, Torben Hansen, Denmark

Overweight genetic susceptibility and the risk of LADA – latent autoimmune diabetes in adults
Rebecka Hjort, Josefin Edwall Löfvenborg, Emma Ahlqvist, Lars Alfredsson, Leif Groop, Bahareh Rasouli, Anders Rosengren,  Tiinamaija Tuomi, Sofia Carlsso, Sweden and Finland

Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes
Christoph Nowak, Axel C. Carlsson, Carl Johan Östergren, Fredrik H. Nyström, Moudud Alam, Tobias Rudholm Feldreich, Johan Sundström, Juan Jesus Carrero Roig, Pharm, Jerzy Leppert, Pär Hedberg, Egil Henriksen, Antonio C. Cordeiro, Vilmantas Giedraitis, Lars Lind, Erik Ingelsson, Tove Fall, Johan Ärnlöv, Sweden
CANCELLED

Second line treatment after metformin monotherapy of type 2 diabetes in a real life setting 2006 to 2015 – nationwide data comparison between Denmark, Finland, Norway and Sweden
Jorma Lahtela, Johan Eriksson, Frederik Persson, Johan Bodegard, Thomas Nyström, David Nathanson, Marcus Thuresson, Majken Linnemann Jensen, Marit E Jørgensen, Kåre I Birkeland, Hanne L Gulseth, Anna Norhammar, Fabian Hoti, Jan W Eriksson, Finland, Denmark, Norway, Sweden

Metformin versus insulin in gestational diabetes: 9-year follow-up study -effects on the child
Elisa Paavilainen, Kristiina Tertti, Tapani Rönnemaa, Marja Vääräsmäki, Hilkka Ijäs, Päivi Tossavainen, Riitta Veijola, Harri Niinikoski, Finland

Comparison of amino acid profiles in women with gestational diabetes treated with metformin or insulin
Mikael Huhtala, Kristiina Tertti and Tapani Rönnemaa, Finland